Caption Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Sell
170,000
-580,000
-77% -$33.8M 0.06% 330
2025
Q4
$40.5M Buy
750,000
+655,000
+689% +$31.5M 0.28% 80
2025
Q3
$4.28M Sell
95,000
-125,000
-57% -$5.84M 0.03% 549
2025
Q2
$10.2M Buy
220,000
+150,000
+214% +$7.36M 0.11% 201
2025
Q1
$4.27M Buy
+70,000
New +$4.08M 0.04% 444
2024
Q4
Sell
-68,600
Closed -$3.55M 1471
2024
Q3
$3.55M Buy
+68,600
New +$3.22M 0.06% 383
2023
Q4
Sell
-448,500
Closed -$26M 1357
2023
Q3
$26M Sell
448,500
-200,000
-31% -$12.3M 0.4% 48
2023
Q2
$41.5M Buy
648,500
+200,000
+45% +$13.4M 0.73% 14
2023
Q1
$31.1M Sell
448,500
-97,500
-18% -$6.88M 0.6% 35
2022
Q4
$39.3M Buy
546,000
+348,500
+176% +$26.3M 0.61% 24
2022
Q3
$14M Sell
197,500
-176,900
-47% -$12.8M 0.19% 107
2022
Q2
$28.8M Buy
374,400
+132,800
+55% +$10.1M 0.4% 43
2022
Q1
$17.6M Buy
+241,600
New +$16.2M 0.21% 101
2021
Q3
Sell
-64,000
Closed -$4.28M 1518
2021
Q2
$4.28M Buy
+64,000
New +$4.17M 0.06% 410
2020
Q3
Sell
-220,000
Closed -$12.9M 1038
2020
Q2
$12.9M Buy
+220,000
New +$13.2M 0.43% 34
2020
Q1
Sell
-113,500
Closed -$7.29M 867
2019
Q4
$7.29M Buy
113,500
+30,000
+36% +$1.72M 0.24% 97
2019
Q3
$4.24M Hold
83,500
0.22% 121
2019
Q2
$3.79M Sell
83,500
-415,000
-83% -$19.3M 0.19% 156
2019
Q1
$23.8M Buy
+498,500
New +$24.8M 1.31% 6
2018
Q1
Sell
-194,400
Closed -$11.9M 230
2017
Q4
$11.9M Buy
+194,400
New +$12.2M 1.24% 16

Other funds holding BMY

Caption Management's BMY Position: Q1 2026 in Review

Caption Management sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 537,700 shares — an estimated $31.3M sold.

Caption Management first reported a position in BMY in Q4 2017 and held it in 16 quarters. The position peaked at $29M in Q4 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Caption Management reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
  • Caption Management sold 537,700 Bristol-Myers Squibb shares in Q1 2026, an estimated $31.3M.
  • Caption Management first reported a position in Bristol-Myers Squibb in Q4 2017 and held it in 16 quarters.
  • Caption Management's Bristol-Myers Squibb position peaked at $29M in Q4 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Caption Management's 13F filing for Q1 2026, filed 15 May 2026.